(CLIME-B) Climeon (publ) - Ratings and Ratios
Exchange: ST •
Country: Sweden •
Currency: SEK •
Type: Common Stock •
ISIN: SE0009973548
Heat, Power, Units, Modules, Waste
CLIME-B EPS (Earnings per Share)
CLIME-B Revenue
Description: CLIME-B Climeon (publ)
Climeon AB (publ) is a Swedish renewable electricity company with a market capitalization of 171.20M SEK. The stock has exhibited significant volatility, with a beta of 1.997, indicating that its price movements are nearly twice as volatile as the overall market.
The companys financials are characterized by a negative Return on Equity (RoE) of -45.03%, suggesting that it is currently unprofitable. The P/E ratio is not available, likely due to the companys negative earnings. Key drivers of the companys economic performance include its ability to scale its renewable energy solutions, manage costs, and navigate regulatory environments.
To assess the companys prospects, key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow should be closely monitored. Additionally, the companys ability to secure new projects, expand its customer base, and improve its operational efficiency will be crucial in determining its future financial health.
From a trading perspective, the stocks recent price action has been relatively stable, with a 20-day Simple Moving Average (SMA) of 4.04 and a 50-day SMA of 4.08. The Average True Range (ATR) of 0.15 (3.63%) suggests moderate intraday volatility. Investors should consider these technical indicators in conjunction with fundamental analysis to make informed decisions.
CLIME-B Stock Overview
| Market Cap in USD | 17m |
| Sub-Industry | Renewable Electricity |
| IPO / Inception |
CLIME-B Stock Ratings
| Growth Rating | -73.2% |
| Fundamental | 39.2% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -42.3% |
| Analyst Rating | - |
CLIME-B Dividends
Currently no dividends paidCLIME-B Growth Ratios
| Growth Correlation 3m | -20.9% |
| Growth Correlation 12m | -29.8% |
| Growth Correlation 5y | -97.6% |
| CAGR 5y | -59.19% |
| CAGR/Max DD 5y | -0.60 |
| Sharpe Ratio 12m | -0.84 |
| Alpha | -103.57 |
| Beta | 5.185 |
| Volatility | 86.73% |
| Current Volume | 14.3k |
| Average Volume 20d | 22.6k |
| Stop Loss | 3.8 (-5%) |
| Signal | 2.18 |
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-118.7m TTM) > 0 and > 6% of Revenue (6% = 2.13m TTM) |
| FCFTA -0.40 (>2.0%) and ΔFCFTA -10.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 201.2% (prev 502.0%; Δ -300.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.22 (>3.0%) and CFO -63.0m > Net Income -118.7m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (39.1m) change vs 12m ago 79.04% (target <= -2.0% for YES) |
| Gross Margin -48.36% (prev -175.1%; Δ 126.8pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 10.72% (prev 5.06%; Δ 5.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -14.46 (EBITDA TTM -75.2m / Interest Expense TTM 7.66m) >= 6 (WARN >= 3) |
Altman Z'' -55.85
| (A) 0.25 = (Total Current Assets 97.5m - Total Current Liabilities 26.1m) / Total Assets 282.4m |
| (B) -4.17 = Retained Earnings (Balance) -1.18b / Total Assets 282.4m |
| warn (B) unusual magnitude: -4.17 — check mapping/units |
| (C) -0.33 = EBIT TTM -110.8m / Avg Total Assets 331.0m |
| (D) -39.69 = Book Value of Equity -1.17b / Total Liabilities 29.5m |
| Total Rating: -55.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 39.22
| 1. Piotroski 0.50pt = -4.50 |
| 2. FCF Yield -83.01% = -5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC data missing |
| 7. RoE -45.03% = -2.50 |
| 8. Rev. Trend 34.72% = 1.74 |
| 9. Rev. CAGR 16.51% = 2.06 |
| 10. EPS Trend -3.20% = -0.08 |
| 11. EPS CAGR -31.72% = -2.50 |
What is the price of CLIME-B shares?
As of August 31, 2025, the stock is trading at SEK 4.00 with a total of 14,339 shares traded.
Over the past week, the price has changed by +11.11%, over one month by -1.23%, over three months by +2.56% and over the past year by -32.55%.
Over the past week, the price has changed by +11.11%, over one month by -1.23%, over three months by +2.56% and over the past year by -32.55%.
Is Climeon (publ) a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Climeon (publ) (ST:CLIME-B) is currently (August 2025)
a stock to sell. It has a ValueRay Fundamental Rating of 39.22 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLIME-B is around 1.73 SEK . This means that CLIME-B is currently overvalued and has a potential downside of -56.75%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLIME-B is around 1.73 SEK . This means that CLIME-B is currently overvalued and has a potential downside of -56.75%.
Is CLIME-B a buy, sell or hold?
Climeon (publ) has no consensus analysts rating.
What are the forecasts/targets for the CLIME-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4 | 0% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.1 | -48% |
CLIME-B Fundamental Data Overview
Market Cap USD = 17.2m (163.9m SEK * 0.105 SEK.USD)
Market Cap SEK = 163.9m (163.9m SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 26.4m SEK (Cash And Short Term Investments, last quarter)
P/S = 3.6784
P/B = 0.6483
Beta = 1.997
Revenue TTM = 35.5m SEK
EBIT TTM = -110.8m SEK
EBITDA TTM = -75.2m SEK
Long Term Debt = unknown (0.0)
Short Term Debt = unknown (0.0)
Debt = unknown
Net Debt = -26.4m SEK (from netDebt column, last quarter)
Enterprise Value = 137.5m SEK (163.9m + (null Debt) - CCE 26.4m)
Interest Coverage Ratio = -14.46 (Ebit TTM -110.8m / Interest Expense TTM 7.66m)
FCF Yield = -83.01% (FCF TTM -114.1m / Enterprise Value 137.5m)
FCF Margin = -321.7% (FCF TTM -114.1m / Revenue TTM 35.5m)
Net Margin = -334.4% (Net Income TTM -118.7m / Revenue TTM 35.5m)
Gross Margin = -48.36% ((Revenue TTM 35.5m - Cost of Revenue TTM 52.6m) / Revenue TTM)
Tobins Q-Ratio = -0.12 (set to none) (Enterprise Value 137.5m / Book Value Of Equity -1.17b)
Interest Expense / Debt = unknown (Interest Expense 860.0k / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 3.74 (Total Current Assets 97.5m / Total Current Liabilities 26.1m)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt -26.4m / EBITDA -75.2m)
Debt / FCF = none (Debt none / FCF TTM -114.1m)
Total Stockholder Equity = 263.5m (last 4 quarters mean)
RoA = -42.02% (Net Income -118.7m, Total Assets 282.4m )
RoE = -45.03% (Net Income TTM -118.7m / Total Stockholder Equity 263.5m)
RoCE = -42.04% (Ebit -110.8m / (Equity 263.5m + L.T.Debt 0.0))
RoIC = unknown (NOPAT none, Invested Capital 263.5m, Ebit -110.8m)
WACC = unknown (E(163.9m)/V(0.0) * Re(25.12%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(none)))
Shares Correlation 5-Years: 0.0 | Cagr: -9.71%
Discount Rate = 25.12% (= CAPM, Blume Beta Adj.) -> capped to 17.95% (dynamic)
Fair Price DCF = unknown (Cash Flow -114.1m)
Revenue Correlation: 34.72 | Revenue CAGR: 16.51%
Rev Growth-of-Growth: 5.35
EPS Correlation: -3.20 | EPS CAGR: -31.72%
EPS Growth-of-Growth: 37.77
Market Cap SEK = 163.9m (163.9m SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 26.4m SEK (Cash And Short Term Investments, last quarter)
P/S = 3.6784
P/B = 0.6483
Beta = 1.997
Revenue TTM = 35.5m SEK
EBIT TTM = -110.8m SEK
EBITDA TTM = -75.2m SEK
Long Term Debt = unknown (0.0)
Short Term Debt = unknown (0.0)
Debt = unknown
Net Debt = -26.4m SEK (from netDebt column, last quarter)
Enterprise Value = 137.5m SEK (163.9m + (null Debt) - CCE 26.4m)
Interest Coverage Ratio = -14.46 (Ebit TTM -110.8m / Interest Expense TTM 7.66m)
FCF Yield = -83.01% (FCF TTM -114.1m / Enterprise Value 137.5m)
FCF Margin = -321.7% (FCF TTM -114.1m / Revenue TTM 35.5m)
Net Margin = -334.4% (Net Income TTM -118.7m / Revenue TTM 35.5m)
Gross Margin = -48.36% ((Revenue TTM 35.5m - Cost of Revenue TTM 52.6m) / Revenue TTM)
Tobins Q-Ratio = -0.12 (set to none) (Enterprise Value 137.5m / Book Value Of Equity -1.17b)
Interest Expense / Debt = unknown (Interest Expense 860.0k / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 3.74 (Total Current Assets 97.5m / Total Current Liabilities 26.1m)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt -26.4m / EBITDA -75.2m)
Debt / FCF = none (Debt none / FCF TTM -114.1m)
Total Stockholder Equity = 263.5m (last 4 quarters mean)
RoA = -42.02% (Net Income -118.7m, Total Assets 282.4m )
RoE = -45.03% (Net Income TTM -118.7m / Total Stockholder Equity 263.5m)
RoCE = -42.04% (Ebit -110.8m / (Equity 263.5m + L.T.Debt 0.0))
RoIC = unknown (NOPAT none, Invested Capital 263.5m, Ebit -110.8m)
WACC = unknown (E(163.9m)/V(0.0) * Re(25.12%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(none)))
Shares Correlation 5-Years: 0.0 | Cagr: -9.71%
Discount Rate = 25.12% (= CAPM, Blume Beta Adj.) -> capped to 17.95% (dynamic)
Fair Price DCF = unknown (Cash Flow -114.1m)
Revenue Correlation: 34.72 | Revenue CAGR: 16.51%
Rev Growth-of-Growth: 5.35
EPS Correlation: -3.20 | EPS CAGR: -31.72%
EPS Growth-of-Growth: 37.77